Latest Ptsd Therapy News

Page 1 of 1

Emyria’s PTSD Therapy Shows Lasting Relief, Partners with ANU for Research

Emyria reports sustained six-month improvements in treatment-resistant PTSD patients and announces a strategic research collaboration with Australian National University to advance mental health care models.

Ada Torres

28 May 2025

Emyria’s MDMA Therapy Shows Lasting PTSD Relief in Early Clinical Data

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

Ada Torres

4 Feb 2025

Emyria Advances Mental Health Therapies with $2.5M Capital Boost and New Leadership

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

Ada Torres

31 Jan 2025